“…MMP9 [133], S100A12 [134], SOCS3 [135], MMP8 [136], CRISP3 [137], S100A9 [138], RETN (resistin) [139], IL1RN [140], TLR4 [141], GGT1 [142], CTSD (cathepsin D) [143], FASLG (Fas ligand) [144], CCR4 [145], FCRL3 [146] and ABCF1 [147] were revealed and regarded as diagnostic biomarker in pancreatitis. Accumulating evidence shows that MMP9 [133], S100A12 [148], HP (haptoglobin) [149], OSM (oncostatin M) [150], PRDM5 [151], TSPO (translocator protein) [152], IL18RAP [153], ADAMDEC1 [154], IL1RN [155], SCN9A [156], FADS2 [157], NCF4 [158], SERPINB1 [159], TNFRSF13B [160], IL2RB [161], DLG5 [162], FASLG (Fas ligand) [163], GPR68 [164], IL2RA [161], TCF4 [165], TAGAP (T cell activation RhoGTPase activating protein) [166], ABCB1 [167], FCRL3 [168], ITGB7 [169], PTGER4 [170] and TRAF3IP2 [171] are altered expression in gastrointestinal complications. Recent studies reported that MMP9 [133], S100A12 [172], IGF2 [173], GPR84 [174], SOCS3 [175], IGFBP2 [176], HP (haptoglobin) [177], MMP8 [178], OSM (oncostatin M) [179], TLR5 [180], S100A9 [181], PLIN5 [182], NRG1 [183], LCN2 [184], TSPO (translocator protein) [185], PLAU (plasminogen activator, urokinase) [186], PPBP (pro-platelet basic protein) [187], UPP1 [188], ALOX5 [189], IL1RN [190], CYP1B1 [191], DGAT2 [192], MSRA (methionine sulfoxidereductase A) [193], ADAM9 [194], CPEB4 [195], IRS2 [196], FADS2 [197], SLC22A4 [198], PFKFB3 [199], CTSD (cathepsin D) […”